Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden.

[1]  P. Klarskov,et al.  Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 , 2008, Scandinavian journal of urology and nephrology.

[2]  B. Fagerberg,et al.  Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. , 2006, The Journal of clinical endocrinology and metabolism.

[3]  J. Murabito,et al.  Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men , 2006, Annals of Internal Medicine.

[4]  O. Johnell,et al.  Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[6]  S. Cummings,et al.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.

[7]  O. Raitakari,et al.  Increased carotid atherosclerosis in andropausal middle-aged men. , 2005, Journal of the American College of Cardiology.

[8]  P. J. Larsen,et al.  Novel Associations Between Bioavailable Estradiol and Adipokines in Elderly Women With Different Phenotypes of Obesity: Implications for Atherogenesis , 2004, Circulation.

[9]  Eric M Isselbacher,et al.  Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. , 2004, Circulation.

[10]  D. Grobbee,et al.  Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men , 2004, Circulation.

[11]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[12]  Ravinder J. Singh,et al.  Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. , 2004, Clinical chemistry.

[13]  C. Schmid,et al.  Association between Estrogen receptor α gene variation and cardiovascular disease , 2003 .

[14]  P. Hopkins,et al.  Estrogen receptor 1 variants and coronary artery disease: shedding light into a murky pool. , 2003, Journal of the American Medical Association (JAMA).

[15]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[16]  A. von Eckardstein,et al.  Androgens and coronary artery disease. , 2003, Endocrine reviews.

[17]  M. Bots,et al.  Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.

[18]  D. Levy,et al.  Chorioamnionitis and cerebral palsy in term and near-term infants , 2004 .

[19]  J. Price,et al.  Steroid sex hormones for lower limb atherosclerosis. , 2012, The Cochrane database of systematic reviews.

[20]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[21]  M. Ala-opas,et al.  Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 , 2002, Scandinavian journal of urology and nephrology.

[22]  Markus Perola,et al.  Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study , 2002, Journal of Molecular Medicine.

[23]  Robert Selzer,et al.  Estrogen in the Prevention of Atherosclerosis , 2001, Annals of Internal Medicine.

[24]  A. Lusis,et al.  Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Azen,et al.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. , 2001, Annals of internal medicine.

[26]  D. Grobbee,et al.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.

[27]  J. Price,et al.  Steroid sex hormones for lower limb atherosclerosis. , 2000, The Cochrane database of systematic reviews.

[28]  P. Komesaroff,et al.  Cardiovascular Actions of Estrogens in Men , 1999 .

[29]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[30]  P. Komesaroff,et al.  Clinical review 110: Cardiovascular actions of estrogens in men. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[32]  M. Ruutu,et al.  Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. Finnprostate Group. , 1998, British journal of urology.

[33]  J. Price,et al.  Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study , 1997, Steroids.

[34]  B. Fagerberg,et al.  Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk. The value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Risk Intervention Study (RIS) Group. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[35]  E. Crawford,et al.  Estrogens in the treatment of prostate cancer. , 1995, The Journal of urology.

[36]  B. Zumoff.  Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. , 1985, The American journal of medicine.

[37]  The Coronary Drug Project. Initial findings leading to modifications of its research protocol. , 1970, JAMA.